Filings & Financials

Investor Resources
Contact Us
Investor ResourcesFilings & Financials

Financials

Financial Statements
2025
Q1Q2Q3Q4
2024
2023
2022
2021
2020
2019
MD&A
2025
Q1Q2Q3Q4
2024
2023
2022
2021
2020
2019

Regulatory Filings

For a full list of Cardiol Therapeutics’ regulatory filings, please visit SEDAR (Canadian Public Filings) or EDGAR (US Public Filings).

Financial Downloads

2024
Cardiol Therapeutics – Year End Financial Statements
2024
Cardiol Therapeutics – Year End MD&A
2024
Cardiol Therapeutics – Annual Information Form
2023
Cardiol Therapeutics – Year End Financial Statements
2023
Cardiol Therapeutics – Year End MD&A
2023
Cardiol Therapeutics – Annual Report on Form 20-F
2022
Cardiol Therapeutics – Year End Financial Statements
2022
Cardiol Therapeutics – Year End MD&A
2022
Cardiol Therapeutics – Annual Report on Form 20-F
2021
Cardiol Therapeutics – Year End Financial Statements
2021
Cardiol Therapeutics – Year End MD&A
2021
Cardiol Therapeutics – Annual Information Form
2020
Cardiol Therapeutics – Year End Financial Statements
2020
Cardiol Therapeutics – Year End MD&A
2019
Cardiol Therapeutics – Year End Financial Statements
2019
Cardiol Therapeutics – Year End MD&A
2018
Cardiol Therapeutics – Year End Financial Statements
2018
Cardiol Therapeutics – Year End MD&A
2025 Cardiol Therapeutics. All right reserved.